Alnylam Pharmaceuticals Inc ALNY

NAS: ALNY | ISIN: US02043Q1076 10/04/2026

322,11 USD (+0,26%)

(+0,26%) 10/04/2026

Grafiek Alnylam Pharmaceuticals Inc

Grafiek Alnylam Pharmaceuticals Inc

1 dag1d 0,26%
1 week1w -2,49%
1 maand1m -0,08%
3 maanden3m -13,16%
6 maanden6m -30,05%
1 jaar1j 42,35%
5 jaar5j 138,55%

Alnylam Pharmaceuticals Inc in het nieuws

Toon enkel gratis nieuws

18 september 2025 · Alnylam Pharmaceuticals joins Alliance for Genomic Discovery, expanding diverse clinical genomic dataset to drive precision medicine · Persbericht

30 april 2024 · Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in Europe and Israel to Commercialize RNAi Therapeutics in additional LATAM and APAC markets including Australia · Persbericht

9 maart 2023 · Alnylam Pharmaceuticals and Medison Pharma Announce the Expansion of Their Collaboration to a Multi-Regional Partnership to Commercialize RNAi Therapeutics · Persbericht

15 september 2022 · Regeneron and Alnylam Report Promising Data from Ongoing Phase 1 Study of ALN-HSD in NASH Patients and Healthy Volunteers · Persbericht

9 december 2021 · Direxion Launches mRNA ETF (MSGR) · Persbericht

Profiel Alnylam Pharmaceuticals Inc

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Website: www.alnylam.com

Hoofdzetel: Cambridge, Massachusetts Verenigde Staten

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe